Clinical Trial

Olive Leaf Extracts in the Control of Diabet

Study acronym: Dia-Athr
Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated June 3, 2025 (before its estimated September 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study will be carried out in 2 emergency departments (at the exit of the emergency room) and 2 external consultations (endocrinology of the CHU FB Monastir and diabetology consultation, Jemmal hospital). Patients over 18 years of age with: -Diabets
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-10-29; most recent amendment 2025-06-01.
Status change: Not Yet Recruiting → Recruiting 2023-03-13
Trial Details
NCT Number NCT05605704
Lead Sponsor University of Monastir
Conditions Diabetes Mellitus, Type 2
Enrollment 500 participants
Start Date 2023-01-01
Primary Completion 2025-09-15 (estimated)
Study Completion 2025-12-15 (estimated)
Updated on ClinicalTrials.gov 2025-06-03